世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000040945

認知症治療薬市場:規模、シェア、動向分析レポート、およびセグメント予測、2025-2030

Grand View Research Inc.

Dementia Treatment Market Size, Share & Trends Analysis Report, And Segment Forecasts, 2025 - 2030

発刊日 2025/02

言語英語

体裁PDF/100ページ

ライセンス/価格100ページ

0000040945

Individual
Team
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

認知症治療の市場規模、シェア、動向分析レポート:適応症別、薬剤クラス別、投与経路別 (経口、経皮パッチ、注射用)、流通チャネル別、地域別、およびセグメント予測、2025-2030

認知症治療の市場規模と動向

認知症治療薬世界市場の規模は、2024年に180億3000万ドルと推定され、2025年から2030年にかけて8.0%のCAGRで成長すると予測されます。市場の成長は、高い疾患有病率、高齢者人口の増加、新規治療薬の導入、および市場での研究開発活動の増加に起因しています。例えば、NCBIによると、2023年に米国では65歳以上の約670万人がアルツハイマー型認知症を患っており、2060年には約1,380万人に達すると推定されています。さらに、この疾患について人々を教育するための政府の支援的な取り組みの増加と意識向上プログラムの増加が、市場の成長をさらに促進すると予想されます。認知症の有病率の増加は、市場の成長を牽引する主な要因の1つです。

レポート詳細

目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Indication
1.2.2. Drug Class
1.2.3. Route of Administration
1.2.4. Distribution Channel
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Dementia Treatment Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.3. Pipeline Analysis

Chapter 4. Dementia Treatment Market: Indication Business Analysis
4.1. Indication Market Share, 2024 & 2030
4.2. Indication Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Indication, 2018 to 2030 (USD Million)
4.4. Alzheimer’s Disease Dementia
4.4.1. Alzheimer’s Disease Dementia Market, 2018 - 2030 (USD Million)
4.5. Vascular Dementia
4.5.1. Vascular Dementia Market, 2018 - 2030 (USD Million)
4.6. Lewy Body Dementia
4.6.1. Lewy Body Dementia Market, 2018 - 2030 (USD Million)
4.7. Frontotemporal Dementia (FTD)
4.7.1. Frontotemporal Dementia (FTD) Market, 2018 - 2030 (USD Million)
4.8. Parkinson Disease Dementia
4.8.1. Parkinson Disease Dementia Market, 2018 - 2030 (USD Million)
4.9. Others
4.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Dementia Treatment Market: Drug Class Business Analysis
5.1. Drug Class Market Share, 2024 & 2030
5.2. Drug Class Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2018 to 2030 (USD Million)
5.4. Cholinesterase Inhibitors
5.4.1. Cholinesterase Inhibitors Market, 2018 - 2030 (USD Million)
5.5. NMDA Receptor Antagonist
5.5.1. NMDA Receptor Antagonist Market, 2018 - 2030 (USD Million)
5.6. MAO Inhibitors
5.6.1. MAO Inhibitors Market, 2018 - 2030 (USD Million)
5.7. Combination Drugs
5.7.1. Combination Drugs Market, 2018 - 2030 (USD Million)
5.8. Others
5.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Dementia Treatment Market: Route of Administration Business Analysis
6.1. Route of Administration Market Share, 2024 & 2030
6.2. Route of Administration Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
6.4. Oral
6.4.1. Oral Market, 2018 - 2030 (USD Million)
6.5. Transdermal Patch
6.5.1. Transdermal Patch Market, 2018 - 2030 (USD Million)
6.6. Injectable
6.6.1. Injectable Market, 2018 - 2030 (USD Million)

Chapter 7. Dementia Treatment Market: Distribution Channel Business Analysis
7.1. Distribution Channel Market Share, 2024 & 2030
7.2. Distribution Channel Segment Dashboard
7.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
7.4. Hospital Pharmacies
7.4.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
7.5. Retail Pharmacies
7.5.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
7.6. Online Pharmacies
7.6.1. Online Pharmacies Market, 2018 - 2030 (USD Million)

Chapter 8. Dementia Treatment Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.4. North America
8.4.1. North America Dementia Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
8.4.2. U.S.
8.4.2.1. Key Country Dynamics
8.4.2.2. Regulatory Framework
8.4.2.3. Competitive Insights
8.4.2.4. U.S. Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.3. Canada
8.4.3.1. Key Country Dynamics
8.4.3.2. Regulatory Framework
8.4.3.3. Competitive Insights
8.4.3.4. Canada Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.4. Mexico
8.4.4.1. Key Country Dynamics
8.4.4.2. Regulatory Framework
8.4.4.3. Competitive Insights
8.4.4.4. Mexico Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5. Europe
8.5.1. Europe Dementia Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
8.5.2. UK
8.5.2.1. Key Country Dynamics
8.5.2.2. Regulatory Framework
8.5.2.3. Competitive Insights
8.5.2.4. UK Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.3. Germany
8.5.3.1. Key Country Dynamics
8.5.3.2. Regulatory Framework
8.5.3.3. Competitive Insights
8.5.3.4. Germany Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.4. France
8.5.4.1. Key Country Dynamics
8.5.4.2. Regulatory Framework
8.5.4.3. Competitive Insights
8.5.4.4. France Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.5. Italy
8.5.5.1. Key Country Dynamics
8.5.5.2. Regulatory Framework
8.5.5.3. Competitive Insights
8.5.5.4. Italy Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.6. Spain
8.5.6.1. Key Country Dynamics
8.5.6.2. Regulatory Framework
8.5.6.3. Competitive Insights
8.5.6.4. Spain Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.7. Norway
8.5.7.1. Key Country Dynamics
8.5.7.2. Regulatory Framework
8.5.7.3. Competitive Insights
8.5.7.4. Norway Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.8. Denmark
8.5.8.1. Key Country Dynamics
8.5.8.2. Regulatory Framework
8.5.8.3. Competitive Insights
8.5.8.4. Denmark Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.9. Sweden
8.5.9.1. Key Country Dynamics
8.5.9.2. Regulatory Framework
8.5.9.3. Competitive Insights
8.5.9.4. Sweden Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6. Asia Pacific
8.6.1. Asia Pacific Dementia Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
8.6.2. Japan
8.6.2.1. Key Country Dynamics
8.6.2.2. Regulatory Framework
8.6.2.3. Competitive Insights
8.6.2.4. Japan Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.3. China
8.6.3.1. Key Country Dynamics
8.6.3.2. Regulatory Framework
8.6.3.3. Competitive Insights
8.6.3.4. China Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.4. India
8.6.4.1. Key Country Dynamics
8.6.4.2. Regulatory Framework
8.6.4.3. Competitive Insights
8.6.4.4. India Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.5. South Korea
8.6.5.1. Key Country Dynamics
8.6.5.2. Regulatory Framework
8.6.5.3. Competitive Insights
8.6.5.4. South Korea Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.6. Australia
8.6.6.1. Key Country Dynamics
8.6.6.2. Regulatory Framework
8.6.6.3. Competitive Insights
8.6.6.4. Australia Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.7. Thailand
8.6.7.1. Key Country Dynamics
8.6.7.2. Regulatory Framework
8.6.7.3. Competitive Insights
8.6.7.4. Thailand Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7. Latin America
8.7.1. Latin America Dementia Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
8.7.2. Brazil
8.7.2.1. Key Country Dynamics
8.7.2.2. Regulatory Framework
8.7.2.3. Competitive Insights
8.7.2.4. Brazil Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7.3. Argentina
8.7.3.1. Key Country Dynamics
8.7.3.2. Regulatory Framework
8.7.3.3. Competitive Insights
8.7.3.4. Argentina Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8. MEA
8.8.1. MEA Dementia Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
8.8.2. South Africa
8.8.2.1. Key Country Dynamics
8.8.2.2. Regulatory Framework
8.8.2.3. Competitive Insights
8.8.2.4. South Africa Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.3. Saudi Arabia
8.8.3.1. Key Country Dynamics
8.8.3.2. Regulatory Framework
8.8.3.3. Competitive Insights
8.8.3.4. Saudi Arabia Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.4. UAE
8.8.4.1. Key Country Dynamics
8.8.4.2. Regulatory Framework
8.8.4.3. Competitive Insights
8.8.4.4. UAE Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.5. Kuwait
8.8.5.1. Key Country Dynamics
8.8.5.2. Regulatory Framework
8.8.5.3. Competitive Insights
8.8.5.4. Kuwait Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape
9.1. Participant Overview
9.2. Company Market Position Analysis
9.3. Company Categorization
9.4. Strategy Mapping
9.5. Company Profiles/Listing
9.5.1. Eisai Co., Ltd.
9.5.1.1. Overview
9.5.1.2. Financial Performance
9.5.1.3. Product Benchmarking
9.5.1.4. Strategic Initiatives
9.5.2. Eli Lilly and Company
9.5.2.1. Overview
9.5.2.2. Financial Performance
9.5.2.3. Product Benchmarking
9.5.2.4. Strategic Initiatives
9.5.3. Novartis AG
9.5.3.1. Overview
9.5.3.2. Financial Performance
9.5.3.3. Product Benchmarking
9.5.3.4. Strategic Initiatives
9.5.4. DAIICHI SANKYO COMPANY, LIMITED
9.5.4.1. Overview
9.5.4.2. Financial Performance
9.5.4.3. Product Benchmarking
9.5.4.4. Strategic Initiatives
9.5.5. AbbVie Inc.
9.5.5.1. Overview
9.5.5.2. Financial Performance
9.5.5.3. Product Benchmarking
9.5.5.4. Strategic Initiatives
9.5.6. Lundbeck
9.5.6.1. Overview
9.5.6.2. Financial Performance
9.5.6.3. Product Benchmarking
9.5.6.4. Strategic Initiatives
9.5.7. Biogen
9.5.7.1. Overview
9.5.7.2. Financial Performance
9.5.7.3. Product Benchmarking
9.5.7.4. Strategic Initiatives
9.5.8. Cipla
9.5.8.1. Overview
9.5.8.2. Financial Performance
9.5.8.3. Product Benchmarking
9.5.8.4. Strategic Initiatives
9.5.9. Sun Pharmaceutical Industries Ltd.
9.5.9.1. Overview
9.5.9.2. Financial Performance
9.5.9.3. Product Benchmarking
9.5.9.4. Strategic Initiatives
9.5.10. Viatris Inc.
9.5.10.1. Overview
9.5.10.2. Financial Performance
9.5.10.3. Product Benchmarking
9.5.10.4. Strategic Initiatives

List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. Global dementia treatment market, by region, 2018 - 2030 (USD Million)
Table 4. Global dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 5. Global dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 6. Global dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 7. Global dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 8. North America dementia treatment market, by country, 2018 - 2030 (USD Million)
Table 9. North America dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 10. North America dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 11. North America dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 12. North America dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 13. U.S. dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 14. U.S. dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 15. U.S. dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 16. U.S. Dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 17. Canada dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 18. Canada dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 19. Canada dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 20. Canada dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 21. Mexico dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 22. Mexico dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 23. Mexico dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 24. Mexico dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 25. Europe dementia treatment market, by country, 2018 - 2030 (USD Million)
Table 26. Europe dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 27. Europe dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 28. Europe dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 29. Europe dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 30. UK dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 31. UK dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 32. UK dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 33. UK Dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 34. Germany dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 35. Germany dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 36. Germany dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 37. Germany dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 38. France dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 39. France dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 40. France dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 41. France Dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 42. Italy dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 43. Italy dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 44. Italy dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 45. Italy dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 46. Spain dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 47. Spain dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 48. Spain dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 49. Spain dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 50. Norway dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 51. Norway dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 52. Norway dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 53. Norway Dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 54. Denmark dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 55. Denmark dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 56. Denmark dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 57. Denmark dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 58. Sweden dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 59. Sweden dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 60. Sweden dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 61. Sweden dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 62. Asia Pacific dementia treatment market, by country, 2018 - 2030 (USD Million)
Table 63. Asia Pacific dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 64. Asia Pacific dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 65. Asia Pacific dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 66. Asia Pacific dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 67. Japan dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 68. Japan dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 69. Japan dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 70. Japan dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 71. China dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 72. China dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 73. China dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 74. China dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 75. India dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 76. India dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 77. India dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 78. India dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 79. Australia dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 80. Australia dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 81. Australia dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 82. Australia dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 83. South Korea dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 84. South Korea dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 85. South Korea dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 86. South Korea dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 87. Thailand dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 88. Thailand dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 89. Thailand dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 90. Thailand dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 91. Latin America dementia treatment market, by country, 2018 - 2030 (USD Million)
Table 92. Latin America dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 93. Latin America dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 94. Latin America dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 95. Latin America dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 96. Brazil dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 97. Brazil dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 98. Brazil dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 99. Brazil dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 100. Argentina dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 101. Argentina dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 102. Argentina dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 103. Argentina dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 104. Middle East & Africa Dementia treatment market, by country, 2018 - 2030 (USD Million)
Table 105. Middle East & Africa dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 106. Middle East & Africa dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 107. Middle East & Africa dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 108. Middle East & Africa dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 109. South Africa dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 110. South Africa dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 111. South Africa dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 112. South Africa dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 113. Saudi Arabia dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 114. Saudi Arabia dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 115. Saudi Arabia dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 116. Saudi Arabia dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 117. UAE dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 118. UAE dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 119. UAE dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 120. UAE dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
Table 121. Kuwait dementia treatment market, by indication, 2018 - 2030 (USD Million)
Table 122. Kuwait dementia treatment market, by drug class, 2018 - 2030 (USD Million)
Table 123. Kuwait dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
Table 124. Kuwait dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Dementia treatment market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Indication and drug class outlook (USD Million)
Fig. 10 Route of administration and distribution channel outlook (USD Million)
Fig. 11 Competitive landscape
Fig. 12 Dementia treatment market dynamics
Fig. 13 Dementia treatment market: Porter’s five forces analysis
Fig. 14 Dementia treatment market: PESTLE analysis
Fig. 15 Dementia treatment market: Indication segment dashboard
Fig. 16 Dementia treatment market: Indication market share analysis, 2024 & 2030
Fig. 17 Alzheimer’s disease dementia market, 2018 - 2030 (USD Million)
Fig. 18 Vascular dementia market, 2018 - 2030 (USD Million)
Fig. 19 Lewy body dementia market, 2018 - 2030 (USD Million)
Fig. 20 Frontotemporal dementia (FTD) market, 2018 - 2030 (USD Million)
Fig. 21 Parkinson disease dementia market, 2018 - 2030 (USD Million)
Fig. 22 Others market, 2018 - 2030 (USD Million)
Fig. 23 Dementia treatment market: Drug class segment dashboard
Fig. 24 Dementia treatment market: Drug class market share analysis, 2024 & 2030
Fig. 25 Cholinesterase inhibitors market, 2018 - 2030 (USD Million)
Fig. 26 NMDA receptor antagonist market, 2018 - 2030 (USD Million)
Fig. 27 MAO inhibitors market, 2018 - 2030 (USD Million)
Fig. 28 Combination drugs market, 2018 - 2030 (USD Million)
Fig. 29 Others market, 2018 - 2030 (USD Million)
Fig. 30 Dementia treatment market: Route of administration segment dashboard
Fig. 31 Dementia treatment market: Route of administration market share analysis, 2024 & 2030
Fig. 32 Oral market, 2018 - 2030 (USD Million)
Fig. 33 Transdermal patch market, 2018 - 2030 (USD Million)
Fig. 34 Injectable market, 2018 - 2030 (USD Million)
Fig. 35 Dementia treatment market: Distribution channel segment dashboard
Fig. 36 Dementia treatment market: Distribution channel market share analysis, 2024 & 2030
Fig. 37 Hospital pharmacies market, 2018 - 2030 (USD Million)
Fig. 38 Retail pharmacies market, 2018 - 2030 (USD Million)
Fig. 39 Online pharmacies market, 2018 - 2030 (USD Million)
Fig. 40 Dementia treatment market revenue, by region
Fig. 41 Regional marketplace: Key takeaways
Fig. 42 Regional marketplace: Key takeaways
Fig. 43 North America dementia treatment market, 2018 - 2030 (USD Million)
Fig. 44 U.S. country dynamics
Fig. 45 U.S. dementia treatment market, 2018 - 2030 (USD Million)
Fig. 46 Canada country dynamics
Fig. 47 Canada dementia treatment market, 2018 - 2030 (USD Million)
Fig. 48 Mexico country dynamics
Fig. 49 Mexico dementia treatment market, 2018 - 2030 (USD Million)
Fig. 50 Europe dementia treatment market, 2018 - 2030 (USD Million)
Fig. 51 UK country dynamics
Fig. 52 UK dementia treatment market, 2018 - 2030 (USD Million)
Fig. 53 Germany country dynamics
Fig. 54 Germany dementia treatment market, 2018 - 2030 (USD Million)
Fig. 55 France country dynamics
Fig. 56 France dementia treatment market, 2018 - 2030 (USD Million)
Fig. 57 Italy country dynamics
Fig. 58 Italy dementia treatment market, 2018 - 2030 (USD Million)
Fig. 59 Spain country dynamics
Fig. 60 Spain dementia treatment market, 2018 - 2030 (USD Million)
Fig. 61 Norway country dynamics
Fig. 62 Norway dementia treatment market, 2018 - 2030 (USD Million)
Fig. 63 Sweden country dynamics
Fig. 64 Sweden dementia treatment market, 2018 - 2030 (USD Million)
Fig. 65 Denmark country dynamics
Fig. 66 Denmark dementia treatment market, 2018 - 2030 (USD Million)
Fig. 67 Asia Pacific dementia treatment market, 2018 - 2030 (USD Million)
Fig. 68 Japan country dynamics
Fig. 69 Japan dementia treatment market, 2018 - 2030 (USD Million)
Fig. 70 China country dynamics
Fig. 71 China dementia treatment market, 2018 - 2030 (USD Million)
Fig. 72 India country dynamics
Fig. 73 India dementia treatment market, 2018 - 2030 (USD Million)
Fig. 74 Australia country dynamics
Fig. 75 Australia dementia treatment market, 2018 - 2030 (USD Million)
Fig. 76 South Korea country dynamics
Fig. 77 South Korea dementia treatment market, 2018 - 2030 (USD Million)
Fig. 78 Thailand country dynamics
Fig. 79 Thailand dementia treatment market, 2018 - 2030 (USD Million)
Fig. 80 Latin America dementia treatment market, 2018 - 2030 (USD Million)
Fig. 81 Brazil country dynamics
Fig. 82 Brazil dementia treatment market, 2018 - 2030 (USD Million)
Fig. 83 Argentina country dynamics
Fig. 84 Argentina dementia treatment market, 2018 - 2030 (USD Million)
Fig. 85 MEA dementia treatment market, 2018 - 2030 (USD Million)
Fig. 86 South Africa country dynamics
Fig. 87 South Africa dementia treatment market, 2018 - 2030 (USD Million)
Fig. 88 Saudi Arabia country dynamics
Fig. 89 Saudi Arabia dementia treatment market, 2018 - 2030 (USD Million)
Fig. 90 UAE country dynamics
Fig. 91 UAE dementia treatment market, 2018 - 2030 (USD Million)
Fig. 92 Kuwait country dynamics
Fig. 93 Kuwait dementia treatment market, 2018 - 2030 (USD Million)
Fig. 94 Company categorization
Fig. 95 Company market position analysis
Fig. 96 Strategic framework

この商品のレポートナンバー

0000040945

TOP